Tack DM, Marder EP, Griffin PM, Cieslak PR, Dunn J, Hurd S, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2015–2018. MMWR Morb Mortal Wkly Rep. 2019;68(16):369–73.
PubMed PubMed Central Google Scholar
2.Kotloff KL, Platts-Mills JA, Nasrin D, Roose A, Blackwelder WC, Levine MM. Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques. Vaccine 2017;35(49 Pt A):6783–6789.
3.Platts-Mills JA, Liu J, Rogawski ET, Kabir F, Lertsethtakarn P, Siguas M, et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018.
4.Tack DM, Ray L, Griffin PM, Cieslak PR, Dunn J, Rissman T, et al. Preliminary incidence and trends of infections with pathogens transmitted commonly through food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2016–2019. MMWR Morb Mortal Wkly Rep. 2020;69(17):509–14.
PubMed PubMed Central Google Scholar
5.Thepault A, Meric G, Rivoal K, Pascoe B, Mageiros L, Touzain F, et al. Genome-wide identification of host-segregating epidemiological markers for source attribution in Campylobacter jejuni. Appl Environ Microbiol. 2017:83(7).
6.Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev. Microbiol. 2007;5(9):665–79.
7.Zilbauer M, Dorrell N, Wren BW, Bajaj-Elliott M. Campylobacter jejuni-mediated disease pathogenesis: an update. Trans R Soc Trop Med Hyg. 2008;102(2):123–9.
8.Taylor DN, Hamer DH, Shlim DR. Medications for the prevention and treatment of travellers’ diarrhea. J Travel Med. 2017;24(suppl_1):S17–22.
9.Riddle MS, Tribble D. Preface: Guidelines for the treatment of travelers’ diarrhea in deployed military personnel. Mil Med. 2017;182(S2):1–3.
PubMed PubMed Central Google Scholar
10.Antibiotic resistance threats in the United States, 2019. 2019.
11.CDC. National Antimicrobial Resistance Monitoring System (NARMS) Now: Human Data. In. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC; 2020.
12.Ricotta EE, Palmer A, Wymore K, Clogher P, Oosmanally N, Robinson T, et al. Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States, 2005–2011. Am J Public Health. 2014;104(7):e108–14.
PubMed PubMed Central Google Scholar
13.Riddle MS, DuPont HL, Connor BA. ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol. 2016;111(5):602–22.
14.Buss JE, Cresse M, Doyle S, Buchan BW, Craft DW, Young S. Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods. Eur J Clin Microbiol Infect Dis. 2019;38(6):1087–93.
CAS PubMed PubMed Central Google Scholar
15.Liu F, Ma R, Wang Y, Zhang L. The clinical importance of Campylobacter concisus and other human hosted campylobacter species. Front Cell Infect Microbiol. 2018;8:243.
PubMed PubMed Central Google Scholar
16.Campagnolo ER, Philipp LM, Long JM, Hanshaw NL. Pet-associated Campylobacteriosis: a persisting public health concern. Zoonoses Public Health. 2017.
17.Amour C, Gratz J, Mduma E, Svensen E, Rogawski ET, McGrath M, et al. Epidemiology and impact of Campylobacter infection in children in 8 low-resource settings: Results From the MAL-ED Study. Clin Infect Dis. 2016;63(9):1171–9.
PubMed PubMed Central Google Scholar
18.Buss SN, Leber A, Chapin K, Fey PD, Bankowski MJ, Jones MK, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol. 2015;53(3):915–25.
PubMed PubMed Central Google Scholar
19.Halpin AL, Gu W, Wise ME, Sejvar JJ, Hoekstra RM, Mahon BE. Post-Campylobacter Guillain Barre Syndrome in the USA: secondary analysis of surveillance data collected during the 2009–2010 novel Influenza A (H1N1) vaccination campaign. Epidemiol Infect. 2018;146(13):1740–5.
PubMed PubMed Central Google Scholar
20.Barrett E, Carr D, Bell ML, Pogreba-Brown K. Post-infectious sequelae after Campylobacter enteric infection: a pilot study in Maricopa County, Arizona. USA. Pilot Feasibility Stud. 2018;4:142.
21.Centers for Disease C, Prevention. Multistate outbreak of Campylobacter jejuni infections associated with undercooked chicken livers--northeastern United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):874–6.
22.Montgomery MP, Robertson S, Koski L, Salehi E, Stevenson LM, Silver R, et al. Multidrug-resistant Campylobacter jejuni Outbreak linked to puppy exposure - United States, 2016–2018. MMWR Morb Mortal Wkly Rep. 2018;67(37):1032–5.
PubMed PubMed Central Google Scholar
23.Davis KR, Dunn AC, Burnett C, McCullough L, Dimond M, Wagner J, et al. Campylobacter jejuni infections associated with raw milk consumption--Utah, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(12):301–5.
24.Burakoff A, Brown K, Knutsen J, Hopewell C, Rowe S, Bennett C, et al. Outbreak of fluoroquinolone-resistant Campylobacter jejuni infections associated with raw milk consumption from a herdshare dairy - Colorado, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(5):146–8.
PubMed PubMed Central Google Scholar
25.Cody AJ, Maiden MC, Strachan NJ, ND MC. A systematic review of source attribution of human campylobacteriosis using multilocus sequence typing. Euro Surveill. 2019:24(43).
26.Tee W, Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis. 1998;26(1):91–6.
27.Gaudreau C, Pilon PA, Sylvestre JL, Boucher F, Bekal S. Multidrug-resistant Campylobacter coli in men who have sex with men, Quebec, Canada, 2015. Emerg Infect Dis. 2016;22(9):1661–3.
PubMed PubMed Central Google Scholar
28.Gaudreau C, Rodrigues-Coutlee S, Pilon PA, Coutlee F, Bekal S. Long-lasting outbreak of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni Subspecies jejuni from 2003 to 2013 in men who have sex with men, Quebec, Canada. Clin Infect Dis. 2015;61(10):1549–52.
29.Marchand-Senecal X, Bekal S, Pilon PA, Sylvestre JL, Gaudreau C. Campylobacter fetus cluster among men who have sex with men, Montreal, Quebec, Canada, 2014–2016. Clin Infect Dis. 2017;65(10):1751–3.
30.Snijders F, Kuijper EJ, de Wever B, van der Hoek L, Danner SA, Dankert J. Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus. Clin Infect Dis. 1997;24(6):1107–13.
31.Jenkin GA, Tee W. Campylobacter upsaliensis-associated diarrhea in human immunodeficiency virus-infected patients. Clin Infect Dis. 1998;27(4):816–21.
32.Gaudreau C, Helferty M, Sylvestre JL, Allard R, Pilon PA, Poisson M, et al. Campylobacter coli outbreak in men who have sex with men, Quebec, Canada, 2010–2011. Emerg Infect Dis. 2013;19(5):764–7.
CAS PubMed PubMed Central Google Scholar
33.Greninger AL, Addetia A, Starr K, Cybulski RJ, Stewart MK, Salipante SJ, et al. International spread of multidrug-resistant campylobacter coli in men who have sex with men in Washington State and Quebec, 2015–2018. Clin Infect Dis. 2019.
34.Gaudreau C, Michaud S. Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Quebec, Canada. Clin Infect Dis. 2003;37(1):131–6.
35.Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ. Experimental Campylobacter jejuni infection in humans. J Infect Dis. 1988;157(3):472–9.
36.Mook P, Gardiner D, Kanagarajah S, Kerac M, Hughes G, Field N, et al. Use of gender distribution in routine surveillance data to detect potential transmission of gastrointestinal infections among men who have sex with men in England. Epidemiol Infect. 2018;146(11):1468–77.
37.Najjar I, Paluca F, Loukidis K, Tarr PE. Recurrent Campylobacter enteritis in patients with hypogammaglobulinemia: review of the literature. J Clin Med. 2020:9(2).
38.Dan M, Parizade M. Chronic high-level multidrug-resistant Campylobacter coli enterocolitis in an agammaglobulinemia patient: Oral gentamicin efficacy. Med Mal Infect. 2020.
39.Arslan H, Inci EK, Azap OK, Karakayali H, Torgay A, Haberal M. Etiologic agents of diarrhea in solid organ recipients. Transpl Infect Dis. 2007;9(4):270–5.
40.Coste JF, Vuiblet V, Moustapha B, Bouin A, Lavaud S, Toupance O, et al. Microbiological diagnosis of severe diarrhea in kidney transplant recipients by use of multiplex PCR assays. J Clin Microbiol. 2013;51(6):1841–9.
PubMed PubMed Central Google Scholar
41.Otto CC, Chen LH, He T, Tang YW, Babady NE. Detection of gastrointestinal pathogens in oncology patients by highly multiplexed molecular panels. Eur J Clin Microbiol Infect Dis. 2017;36(9):1665–72.
CAS PubMed PubMed Central Google Scholar
42.Schvartz B, Garcia M, Wolak-Thierry A, De Champs C, Leveque N. Risk factors of asymptomatic shedding of enteric pathogens in renal transplant recipients. Transpl Infect Dis. 2016;18(3):480–2.
43.Imai N, Uchida D, Hanada M, Sasaki S, Shibagaki Y, Chikaraishi T, et al. A case of Campylobacter enteritis in a renal transplant recipient. Transplantation. 2013;95(12):e78–9.
44.Ban H, Miura K, Ishizuka K, Kaneko N, Taniguchi Y, Nagasawa T, et al. Clinical characteristics of Campylobacter enteritis after pediatric renal transplantation: A retrospective analysis from single center. Transpl Infect Dis. 2019;21(2):e13040.
45.Toussaint N, Goodman D, Langham R, Gock H, Hill P. Haemorrhagic Campylobacter jejuni and CMV colitis in a renal transplant recipient. Nephrol Dial Transplant. 2005;20(4):823–6.
46.Ostman C, Chacko B. Guillain-Barre syndrome post renal transplant: a systematic review. Transpl Infect Dis. 2019;21(1):e13021.
47.Yuki N. Guillain-Barre syndrome and anti-ganglioside antibodies: a clinician-scientist’s journey. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(7):299–326.
CAS PubMed PubMed Central Google Scholar
48.Feodoroff B, Ellstrom P, Hyytiainen H, Sarna S, Hanninen ML, Rautelin H. Campylobacter jejuni isolates in Finnish patients differ according to the origin of infection. Gut Pathog. 2010;2(1):22.
PubMed PubMed Central Google Scholar
49.Samuel MC, Vugia DJ, Shallow S, Marcus R, Segler S, McGivern T, et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996–1999. Clin Infect Dis. 2004;38(Suppl 3):S165–74.
50.Nielsen H, Hansen KK, Gradel KO, Kristensen B, Ejlertsen T, Ostergaard C, et al. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect. 2010;16(1):57–61.
51.Skirrow MB, Jones DM, Sutcliffe E, Benjamin J. Campylobacter bacteraemia in England and Wales, 1981–91. Epidemiol Infect. 1993;110(3):567–73.
留言 (0)